⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9866494 | 0.91 | — | — | |
| SCHEMBL976278 | 0.91 | — | — | |
| SCHEMBL2648 | 0.79 | — | — | |
| SCHEMBL2466994 | 0.74 | — | — | |
| SCHEMBL7695201 | 0.74 | — | — | |
| SCHEMBL3788025 | 0.63 | — | — | |
| SCHEMBL1203 | 0.60 | — | — | |
| SCHEMBL2326 | 0.60 | — | — | |
| SCHEMBL25204735 | 0.55 | — | — | |
| SCHEMBL1112757 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4879 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024151919-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | IFM DUE, INC. (US) | 2024-07-18 | — | — | WO | claimed |
| CN-113088293-B | Liquid crystal medium and liquid crystal display comprising same | 默克专利股份有限公司 | 2024-07-16 | — | — | CN | claimed |
| CN-112004913-B | Liquid crystal mixture and liquid crystal display | 默克专利股份有限公司 | 2024-07-09 | — | — | CN | claimed |
| CN-109943349-B | Liquid-crystalline medium with homeotropic alignment | 默克专利股份有限公司 | 2024-07-05 | — | — | CN | claimed |
| EP-4384503-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | IFM Due, Inc. (US) | 2024-06-19 | — | — | EP | claimed |
| US-20240190883-A1 | KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | BIOTHERYX, INC. (US) | 2024-06-13 | — | — | US | claimed |
| WO-2024118810-A1 | CYCLIC PYRAZOLE DIAMIDE IRE1/XBP1S ACTIVATORS | PROTEGO BIOPHARMA, INC. (US) | 2024-06-06 | — | — | WO | claimed |
| CN-118119595-A | Compounds and compositions for the treatment of diseases associated with STING activity | 艾福姆德尤股份有限公司 | 2024-05-31 | — | — | CN | claimed |
| US-20240174643-A1 | SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | BIOTHERYX, INC. (US) | 2024-05-30 | — | — | US | claimed |
| EP-4015598-B1 | LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME AND COMPOUNDS | MERCK PATENT GMBH (DE) | 2024-05-22 | — | — | EP | claimed |
| US-5015737-A | Antibiotics, bactericides | THE UPJOHN COMPANY (US) | 1991-05-14 | — | — | US | claimed |
| EP-0425622-A1 | MESOGENIC COMPOUNDS. | MERCK PATENT GMBH (DE) | 1991-05-08 | — | — | EP | claimed |
| WO-1991002726-A1 | 5-OXY-2-PHENYLAZINES AND MESOMORPHOUS MEDIUM | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1991-03-07 | — | — | WO | claimed |
| WO-1990015854-A1 | ELECTRO-OPTICAL LIQUID CRYSTAL SYSTEM | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1990-12-27 | — | — | WO | claimed |
| WO-1990013610-A1 | MESOGENIC COMPOUNDS | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1990-11-15 | — | — | WO | claimed |
| EP-0368908-A1 | THERAPEUTICALLY USEFUL $g(b)-LACTAMS | THE UPJOHN COMPANY (US) | 1990-05-23 | — | — | EP | claimed |
| US-4876167-A | CATIONIC POLYMER CONTAINING PHOTOGENERATED 1,3-CYCLOBUTYLENE CROSSLINKING UNITS, WITH ANIONIC DYE | EASTMAN KODAK COMPANY (US) | 1989-10-24 | — | — | US | claimed |
| WO-1989000569-A1 | THERAPEUTICALLY USEFUL beta-LACTAMS | THE UPJOHN COMPANY (US) | 1989-01-26 | — | — | WO | claimed |
| EP-0300636-A1 | Therapeutically useful beta-lactams | THE UPJOHN COMPANY (US) | 1989-01-25 | — | — | EP | claimed |
| WO-1988009322-A1 | CYCLOBUTANE DERIVATIVES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1988-12-01 | — | — | WO | claimed |